Share on LinkedInShare on LinkedIn

ARTICLE · 20 JULY 2013

The FTC's Head Scratcher On FDA Pre-Approval

Lice – just say the word and people start scratching their heads. This week, in an order that compounded that phenomenon, the FTC entered into a settlement with two marketers of the bed bug and head lice treatment Best Yet!, requiring them to obtain FDA pre-approval for any head lice treatment claims in the future.

United StatesMedia, Telecoms, IT, Entertainment

Co-authored by Louis DiLorenzo*

Lice – just say the word and people start scratching their heads.  This week, in an order that compounded that phenomenon, the FTC entered into a settlement with two marketers of the bed bug and head lice treatment Best Yet!, requiring them to obtain FDA pre-approval for any head lice treatment claims in the future.  Earlier this year, however, the FTC refused FTC staff's request to apply this remedy in the POM Wonderful case, despite finding that POM made deceptive claims that its pomegranate juice-based product treated, prevented, or reduced the risk of heart disease, prostate cancer, and erectile dysfunction.  At least one Commissioner thinks the use of this remedy is lousy. 

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from